Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INSITE-DME: Faricimab Treat & Extend vs Fixed Dosing in DME
NCT05610319Phase 4Active, not recruiting
- Sponsor
- McMaster University
- Start
- May 2023
- Primary completion
- Dec 2026
- Modality
- Bispecific Antibodies, Monoclonal Antibodies
- Countries
- 4
01
Overview
A Phase 4 trial of faricimab in diabetic macular edema (DME), sponsored by McMaster University. Started May 2023; status: active, not recruiting.
02
Drugs
faricimab
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT05610319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05610319.